Chandra Asri Pacific Clarifies 1.48% Stake in Prodia
Jakarta, CNBC Indonesia — PT Chandra Asri Pacific Tbk (TPIA), an issuer owned by Prajogo Pangestu, has addressed queries regarding its shareholding in PT Prodia Widyahusada Tbk (PRDA).
This clarification follows data from the Indonesian Central Securities Depository (KSEI) showing shareholders with more than 1% ownership, which revealed that TPIA held 13.89 million shares, or approximately 1.48% of PRDA, as of May 2026.
Suryandi, Director of Human Resources & Corporate Affairs of the Chandra Asri Group, explained that the purchase of PRDA shares in April 2026 was part of the company’s short-term investment portfolio management. He stated that the transaction is not related to any corporate actions or strategic moves by the company.
“As a public company, we understand the market’s attention to every investment activity of the Company. However, we must emphasise that the investment in PRDA shares is part of non-strategic financial portfolio management and is not related to expansion plans, acquisitions, strategic partnerships, or changes in the business focus of Chandra Asri Group,” said Suryandi on Monday, (22/6/2026).
He reaffirmed that the investment in PRDA shares was conducted to optimise the company’s fund management. Therefore, the investment does not reflect a change in the business direction or growth strategy of Chandra Asri Group.
The company emphasised that its shareholding in PRDA does not indicate any involvement of Chandra Asri Group in the operations of the healthcare services company. Furthermore, TPIA is not involved in the management or business decision-making processes at Prodia.
According to Suryandi, Chandra Asri Group remains focused on executing its established long-term growth strategy. In implementing this strategy, the company prioritises the principles of transparency and good corporate governance.
As a listed company, Chandra Asri Group stated that all corporate activities are conducted in accordance with Good Corporate Governance (GCG) principles and applicable capital market regulations. The company also ensures that all material information is communicated through information disclosure mechanisms to regulators and the public.
“Transparency and good corporate governance are vital parts of our commitment to shareholders, investors, and all stakeholders. Therefore, we will continue to ensure that every piece of information conveyed to the public is accurate, relevant, and in accordance with applicable regulations,” added Suryandi.
This development occurs alongside the planned Initial Public Offering (IPO) of PRDA’s subsidiary, PT Prodia Diagnostic Line Tbk (PRDL). The company is offering up to 522.9 million new shares, equivalent to 30% of the fully placed and paid-up capital after the IPO.
In the preliminary prospectus published on 18 June 2026, PRDL set an offering price range of Rp100-Rp120 per share. Consequently, the company has the potential to raise a maximum of Rp62.75 billion from this corporate action.
Source: jawawa.id (https://jawawa.id/newsitem/chandra-asri-pacific-clarifies-1-48-stake-in-prodia-1782114701)
Originally published by CNBC Indonesia (https://www.cnbcindonesia.com/market/20260622133257-17-744607/tpia-buka-suara-usai-disorot-genggam-148-saham-prodia--prda-), translated from Indonesian